Smith & Nephew (SNN) Cash from Financing Activities (2009 - 2024)

Smith & Nephew (SNN) posted quarterly Cash from Financing Activities of $372.0 million for Q4 2024, up 532.56% year-on-year from $58.8 million in Q1 2024, and up 532.56% on a QoQ basis from -$86.0 million in Q4 2023.

Smith & Nephew (SNN) Cash from Financing Activities (2009 - 2024) Analysis & Trends

Smith & Nephew (SNN) has reported Cash from Financing Activities for 16 consecutive years, with $372.0 million the latest figure, recorded in Q4 2024.

  • Quarterly Cash from Financing Activities rose 532.56% year-over-year to $372.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$720.0 million (up 6.13% YoY) and the FY2025 annual result came in at -$955.0 million, down 1010.47% from the prior year.
  • Cash from Financing Activities grew to $372.0 million in Q4 2024 per SNN's latest filing, from -$86.0 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for SNN reached as high as $372.0 million in Q4 2024 and fell as low as -$704.0 million in Q4 2022.
  • A 5-year average of -$79.0 million and a median of -$86.0 million in 2023 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2021 — Cash from Financing Activities sank 192.92% — and 2024, when it surged 532.56%.
  • Year by year, Cash from Financing Activities stood at $325.0 million in 2020, then plunged by 192.92% to -$302.0 million in 2021, then slumped by 133.11% to -$704.0 million in 2022, then surged by 87.78% to -$86.0 million in 2023, then jumped by 532.56% to $372.0 million in 2024.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered $372.0 million, -$86.0 million, and -$704.0 million for Q4 2024, Q4 2023, and Q4 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 17.31 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.51 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -451.20 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -25.00 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -26.93 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 21.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn -97.90 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 372.00 Mn
Dec 31, 2024 372.00 Mn
Dec 31, 2023 -86.00 Mn
Dec 31, 2023 -86.00 Mn
Dec 31, 2022 -704.00 Mn
Dec 31, 2022 -704.00 Mn
Dec 31, 2021 -302.00 Mn
Dec 31, 2021 -302.00 Mn
Dec 31, 2020 325.00 Mn
Dec 31, 2020 325.00 Mn
Dec 31, 2019 303.00 Mn
Dec 31, 2019 303.00 Mn
Dec 31, 2018 553.00 Mn
Dec 31, 2018 553.00 Mn
Dec 31, 2017 -434.00 Mn
Dec 31, 2017 -434.00 Mn
Dec 31, 2016 -529.00 Mn
Dec 31, 2016 -529.00 Mn
Dec 31, 2015 -558.00 Mn
Dec 31, 2015 -558.00 Mn